Causes of preventable drug-related hospital admissions: a qualitative study

被引:56
|
作者
Howard, R. [1 ]
Avery, A. [2 ]
Bissell, P. [3 ]
机构
[1] Univ Reading, Sch Pharm, Reading RG6 6AP, Berks, England
[2] Univ Nottingham, Sch Med, Sch Community Hlth Sci, Nottingham, England
[3] Univ Sheffield, ScHARR, Sheffield, S Yorkshire, England
来源
QUALITY & SAFETY IN HEALTH CARE | 2008年 / 17卷 / 02期
关键词
D O I
10.1136/qshc.2007.022681
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To explore the causes of preventable drug-related admissions (PDRAs) to hospital. Design: Qualitative case studies using semi-structured interviews and medical record review; data analysed using a framework derived from Reason's model of organisational accidents and cascade analysis. Participants: 62 participants, including 18 patients, 8 informal carers, 17 general practitioners, 12 community pharmacists, 3 practice nurses and 4 other members of healthcare staff, involved in events leading up to the patients' hospital admissions. Setting: Nottingham, UK. Results: PDRAs are associated with problems at multiple stages in the medication use process, including prescribing, dispensing, administration, monitoring and help seeking. The main causes of these problems are communication failures ( between patients and healthcare professionals and different groups of healthcare professionals) and knowledge gaps ( about drugs and patients' medical and medication histories). The causes of PDRAs are similar irrespective of whether the hospital admission is associated with a prescribing, monitoring or patient adherence problem. Conclusions: The causes of PDRAs are multifaceted and complex. Technical solutions to PDRAs will need to take account of this complexity and are unlikely to be sufficient on their own. Interventions targeting the human causes of PDRAs are also necessary - for example, improving methods of communication.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [1] Preventable drug-related hospital admissions
    Winterstein, AG
    Sauer, BC
    Hepler, CD
    Poole, C
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (7-8) : 1238 - 1248
  • [2] Drug-related hospital admissions
    Nelson, KM
    Talbert, RL
    PHARMACOTHERAPY, 1996, 16 (04): : 701 - 707
  • [3] DRUG-RELATED HOSPITAL ADMISSIONS
    EINARSON, TR
    ANNALS OF PHARMACOTHERAPY, 1993, 27 (7-8) : 832 - 840
  • [4] DRUG-RELATED HOSPITAL ADMISSIONS
    MCKENNEY, JM
    HARRISON, WL
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1976, 33 (08): : 792 - 795
  • [5] Drug-Related Hospital Admissions
    Ponte, M. L.
    Keller, G.
    Di Girolamo, G.
    Wachs, A.
    DRUG SAFETY, 2010, 33 (10) : 894 - 895
  • [6] DRUG-RELATED ADMISSIONS TO AN AUSTRALIAN HOSPITAL
    STANTON, LA
    PETERSON, GM
    RUMBLE, RH
    COOPER, GM
    POLACK, AE
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1994, 19 (06) : 341 - 347
  • [7] Drug-related hospital admissions with digitalis glycosides
    Schmiedl, S.
    Szymanski, J.
    Rottenkolber, M.
    Drewelow, B.
    Haase, G.
    Hippius, M.
    Reimann, L. R.
    Siegmund, W.
    May, K.
    Hasford, J.
    Thuermann, P. A.
    DRUG SAFETY, 2006, 29 (10) : 945 - 945
  • [8] PREVENTABLE DRUG-RELATED HOSPITAL VISITS AND ADMISSIONS ASSOCIATED WITH LABORATORY OR PHYSIOLOGIC ABNORMALITIES - A SYSTEMATIC-REVIEW
    Wilbur, K.
    Hazi, H.
    El-Badawi, A.
    VALUE IN HEALTH, 2012, 15 (07) : A536 - A537
  • [10] DRUG-RELATED EMERGENCY DEPARTMENT VISITS AND HOSPITAL ADMISSIONS
    PRINCE, BS
    GOETZ, CM
    RIHN, TL
    OLSKY, M
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (07): : 1696 - 1700